Higher Mediterranean diet adherence is associated with lower risk of cognitive impairment in older adults without dementia¶
Claim · All claims
Evidence · 1 study (2 entries) · associationalr3·q3·i2medium
Currency · newest study 2020 · not yet checked against its sources · not reviewed by a person · overdue for a recheck since 2025: baselines and conditions change
Subclaims¶
Reading the evidence codes
q is the design tier, i the impact, n the sample, and the kind with its r
the rigour judged within that kind: what each code means.
This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.
q3 i2 In AREDS, participants in the highest aMED tertile had lower odds of cognitive impairment (3MS <80) than those in the lowest tertile (OR = 0.36, P = .0001). → Keenan Tiarnán D. 2020
q3 i2 In AREDS2, participants in the highest aMED tertile had lower odds of cognitive impairment (TICS-M <30) than those in the lowest tertile (OR = 0.56, P < .0001). → Keenan Tiarnán D. 2020 (2)
Evidence¶
Keenan Tiarnán D. 2020¶
Keenan Tiarnán D., Agrón Elvira, Mares Julie A., Clemons Traci E., van Asten Freekje, Swaroop Anand, Chew Emily Y.; AREDS and AREDS2 Research Groups. (2020). Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2. Alzheimer's & Dementia. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328271/
q3 · i2 · associational · r3
Cross-sectional logistic regression in the AREDS ancillary cognitive study (3,029 participants analyzed), comparing aMED tertile 3 with tertile 1. The article reports an odds ratio of OR = 0.36 (P = .0001; 3MS) and OR = 0.56 (P = .001; composite) for cognitive impairment.
"In AREDS, the odds ratios for cognitive impairment, in aMED tertile 3 (vs 1), were 0.36 (P = .0001; 3MS) Figure 1A and 0.56 (P = .001; composite) Figure 1A."
Keenan Tiarnán D. 2020 (2)¶
Keenan Tiarnán D., Agrón Elvira, Mares Julie A., Clemons Traci E., van Asten Freekje, Swaroop Anand, Chew Emily Y.; AREDS and AREDS2 Research Groups. (2020). Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2. Alzheimer's & Dementia. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328271/
q3 · i2 · associational · r3
Cross-sectional analysis in AREDS2 (3,326 participants analyzed) using telephone-administered TICS-M and composite scores, comparing aMED tertile 3 with tertile 1. The article reports OR = 0.56 (P < .0001; TICS-M) and OR = 0.48 (P < .0001; composite).
"In AREDS2, the equivalent odds ratios were 0.56 (P < .0001; TICS-M) and 0.48 (P < .0001; composite) Figure 1C and equivalent linear regression estimates were +1.0 (P < .0001) and +1.5 (P < .0001) Figure 1D, respectively."
Discussion¶
Related Claims¶
- The aMED–cognition associations persist after adjustment for education level — related
- APOE genotype does not modify the association between Mediterranean diet or fish intake and cognitive function — related
- Higher fish intake is associated with lower risk of cognitive impairment in older adults — related
- Higher Mediterranean diet adherence is associated with higher cognitive test scores, with dose-response associations — related
- Higher Mediterranean diet adherence is not associated with slower cognitive decline over 5 to 10 years — related
- Individual aMED components: vegetable, nut, and moderate alcohol intakes show protective associations with cognitive function — related
- Mediterranean Diet adherence alone shows no significant association with self-regulation, but helps in combination with other habits — related
- Higher fish intake is associated with slower cognitive decline over 5 to 10 years in AREDS2 — related
Page metadata
| Field | Value |
|---|---|
type |
claim |
id |
mediterranean-diet-adherence-lower-cognitive-impairment-risk |
title |
Higher Mediterranean diet adherence is associated with lower risk of cognitive impairment in older adults without dementia |
description |
Higher Mediterranean diet adherence is associated with lower risk of cognitive impairment in older adults without dementia |
status |
review |
evidence_strength |
moderate |
newest_evidence |
2020 |
recheck_by |
2025 |
generated |
by process:wiki-ingest on 2026-10-17 |
trust |
unverified — no one has confirmed this page's content |
sources |
2 — keenan-tiarnán-d-2020, keenan-tiarnán-d-2020-2 |
Frontmatter is the page's machine-readable record — see the Schema & Guide.